Next Generation News and Research

RSS

Viking Systems raises $934,897 through sale of common stock

Viking Systems Inc. announced today that it has increased its cash and liquidity position through the issuance of common stock. The Company raised $934,897 by selling an aggregate of 4,398,050 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.

30 Apr 2010

pSivida announces presentations on bioerodible technologies for degenerative eye disease

pSivida Corp., a leader in the development of back of the eye drug delivery systems, today announced that two poster presentations will be made at the upcoming ARVO meeting on one of pSivida's next generation bioerodible technologies for degenerative eye disease. It marks a key step toward the ability to use pSivida's bioerodible technologies to develop treatments for glaucoma and other degenerative eye diseases, diseases that affect millions of Americans.

30 Apr 2010

New PCA-Rx therapy provides natural toxin removal treatment to Alzheimer's patients

According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.

30 Apr 2010

NWO awards 31 grants in Investment Subsidy NWO Medium programme

The Netherlands Organisation for Scientific Research (NWO) has awarded 31 grants in the Investment Subsidy NWO Medium programme for the acquisition of equipment, the setting up of data collections and the production of software and bibliographies. The total investment amounts to 10 million euro.

30 Apr 2010

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.

30 Apr 2010

SickKids receives $8.9M grant for autism research

A research team co-led by Dr. Stephen Scherer, Senior Scientist at The Hospital for Sick Children (SickKids) was awarded an $8.9 million grant today from the Global Leadership Round in Genomics & Life Sciences (GL(2)), which is part of the Ontario Research Fund (ORF) by the Ministry of Research and Innovation (MRI).

30 Apr 2010

Caliper Life Sciences' first-quarter 2010 GAAP revenues increase 1% to $28.7M

Caliper Life Sciences, Inc., today reported its first quarter 2010 results.

29 Apr 2010

Premier healthcare alliance launches strategic plan to support new models of healthcare delivery

The Premier healthcare alliance has launched a major new strategic plan that will help hospitals leverage performance improvement data and knowledge sharing to prepare for and succeed under healthcare reform.

29 Apr 2010

Oncos Therapeutics completes $5.5M investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a - 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding - 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

29 Apr 2010

Majority of women feel expectations on careers, appearances and healthy lifestyles are more magnified than ever

Today's women juggle many roles from the elusive work-life balance, to aspiring careers to even the 'yummy mummy' phenomenon. In fact, according to a new international women's poll conducted by Environics Research - commissioned by Multibionta(TM) - women across the globe agree career pressures, expectations for maintaining appearances and a healthy lifestyle are more magnified today versus 20 years ago.

29 Apr 2010

RTI Biologics reports revenues of $37.8M for first-quarter 2010

RTI Biologics Inc., a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2010

29 Apr 2010

Talecris Biotherapeutics first-quarter net income increases 35.6% to $45.3 million

Talecris Biotherapeutics Holdings Corp. today announced its financial results for the three months ended March 31, 2010, and filed its first quarter 2010 Form 10-Q with the U.S. Securities and Exchange Commission (SEC).

29 Apr 2010

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.

28 Apr 2010

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.

28 Apr 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

Life Technologies Corporation today announced results for its first quarter ending March 31, 2010. Non-GAAP revenue for the first quarter was $887 million, an increase of 13 percent over the $785 million reported for the first quarter of 2009. Excluding the impact of currency and completed acquisitions and divestitures, organic revenue for the quarter grew 10 percent over the same period in the previous year.

28 Apr 2010

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.

27 Apr 2010

Kinetic Concepts' first-quarter 2010 total revenues increase 3% to $485.8M

Kinetic Concepts, Inc. today reported first quarter 2010 total revenue of $485.8 million, an increase of 3% from the first quarter of 2009. Foreign currency exchange movements favorably impacted total revenue for the first quarter of 2010 by 2% compared to the corresponding period of the prior year.

27 Apr 2010

Illumina announces shipment of HiScanSQ system for research needs

Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.

From Illumina, Inc. 27 Apr 2010

PositiveID, Receptors announce milestone in development of in vivo glucose-sensing RFID microchip

PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.

27 Apr 2010

SuperGen's total revenues for 2010 first-quarter increased to $14.4M

SuperGen, Inc. today reported financial results for the first quarter ended March 31, 2010.

27 Apr 2010

Next Generation News and Research

Viking Systems raises $934,897 through sale of common stock

pSivida announces presentations on bioerodible technologies for degenerative eye disease

New PCA-Rx therapy provides natural toxin removal treatment to Alzheimer's patients

NWO awards 31 grants in Investment Subsidy NWO Medium programme

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

SickKids receives $8.9M grant for autism research

Caliper Life Sciences' first-quarter 2010 GAAP revenues increase 1% to $28.7M

Premier healthcare alliance launches strategic plan to support new models of healthcare delivery

Oncos Therapeutics completes $5.5M investment from HealthCap

Majority of women feel expectations on careers, appearances and healthy lifestyles are more magnified than ever

RTI Biologics reports revenues of $37.8M for first-quarter 2010

Talecris Biotherapeutics first-quarter net income increases 35.6% to $45.3 million

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

Kinetic Concepts' first-quarter 2010 total revenues increase 3% to $485.8M

Illumina announces shipment of HiScanSQ system for research needs

PositiveID, Receptors announce milestone in development of in vivo glucose-sensing RFID microchip

SuperGen's total revenues for 2010 first-quarter increased to $14.4M

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News